India provides Armenia`s leading hematology center with medicine for  treatment of thalassemia

ArmInfo. The Ambassador of  India to Armenia Nilakshi Saha Sinha handed over a new batch of  expensive medicines "Kelfer" to the R. Yolyan Hematology and Oncology  Center of the Ministry of Health of Armenia for the treatment of the  hereditary blood disease - thalassemia.

This disease is characterized by a violation of hemoglobin synthesis.  In Armenia, about 130 people suffer from thalassemia. Patients must  regularly take the drug "Kelfer" throughout their lives.

As part of the visit to the R. Yolyan Center, the Ambassador of  India, accompanied by Deputy Minister of Health Armen Gasparyan and  Director of the Center Hayk Grigoryan, got acquainted with the  conditions in the medical institution, achievements. Then followed  discussions, where the parties considered new areas of  Armenian-Indian cooperation in the field of healthcare.

According to the Indian Embassy in Armenia, the manufacturer of the  medicines "Kelfer" is the Indian pharmaceutical company Cipla.  It  was founded in 1935 and carries out the development, chemical  synthesis and production of more than 1500 names of finished  medicines in various forms. These are antitumor, bronchodilator,  chemotherapeutic, antiretroviral agents, corticosteroids,  immunosuppressants, antibiotics, antidepressants, etc. The company  operates in 150 countries around the world.